相似文献
1
MultiCode-RTx real-time PCR system for detection of subpopulations of K65R human immunodeficiency virus type 1 reverse transcriptase mutant viruses in clinical samples.
J Clin Microbiol. 2006 Nov;44(11):4237-41. doi: 10.1128/JCM.01512-06. Epub 2006 Sep 27.
2
Antagonism between the HIV-1 reverse-transcriptase mutation K65R and thymidine-analogue mutations at the genomic level.
J Infect Dis. 2006 Sep 1;194(5):651-60. doi: 10.1086/505711. Epub 2006 Jul 24.
3
Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.
J Antimicrob Chemother. 2008 Dec;62(6):1191-8. doi: 10.1093/jac/dkn412. Epub 2008 Oct 16.
4
[Process of HIV-1 reverse transcription and its detection by using PCR].
Yao Xue Xue Bao. 2008 Feb;43(2):118-22.
5
Signature nucleotide polymorphisms at positions 64 and 65 in reverse transcriptase favor the selection of the K65R resistance mutation in HIV-1 subtype C.
J Infect Dis. 2009 Oct 15;200(8):1202-6. doi: 10.1086/605894.
6
Plasma RNA viral load in HIV-1 group O infection by real-time PCR.
Methods Mol Biol. 2005;304:221-8. doi: 10.1385/1-59259-907-9:221.
7
Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
AIDS. 2007 Dec;21 Suppl 8:S27-32. doi: 10.1097/01.aids.0000304693.16767.66.
8
Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy.
AIDS. 2008 Jul 31;22(12):1417-23. doi: 10.1097/QAD.0b013e3283034953.
9
Prevalence of the K65R resistance reverse transcriptase mutation in different HIV-1 subtypes in Israel.
J Med Virol. 2009 Sep;81(9):1509-12. doi: 10.1002/jmv.21567.
10
Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
Arch Virol. 2007;152(10):1799-805. doi: 10.1007/s00705-007-1019-9. Epub 2007 Jul 6.
引用本文的文献
1
Drug Susceptibility and Viral Fitness of HIV-1 with Integrase Strand Transfer Inhibitor Resistance Substitution Q148R or N155H in Combination with Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Resistance Substitutions.
Antimicrob Agents Chemother. 2015 Nov 16;60(2):757-65. doi: 10.1128/AAC.02096-15. Print 2016 Feb.
2
Reduced viral fitness and lack of cross-class resistance with integrase strand transfer inhibitor and nucleoside reverse transcriptase inhibitor resistance mutations.
Antimicrob Agents Chemother. 2015;59(6):3441-9. doi: 10.1128/AAC.00040-15. Epub 2015 Mar 30.
3
APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon.
PLoS Genet. 2012;8(3):e1002550. doi: 10.1371/journal.pgen.1002550. Epub 2012 Mar 22.
4
Low-frequency nevirapine resistance at multiple sites may predict treatment failure in infants on nevirapine-based treatment.
J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):225-33. doi: 10.1097/QAI.0b013e3182515730.
5
Allele-specific real-time PCR system for detection of subpopulations of genotype 1a and 1b hepatitis C NS5B Y448H mutant viruses in clinical samples.
J Clin Microbiol. 2011 Sep;49(9):3168-74. doi: 10.1128/JCM.00274-11. Epub 2011 Jun 29.
6
Highly sensitive and quantitative detection of the H274Y oseltamivir resistance mutation in seasonal A/H1N1 influenza virus.
J Clin Microbiol. 2010 Oct;48(10):3517-24. doi: 10.1128/JCM.01031-10. Epub 2010 Jul 28.
7
Detection and quantification of hepatitis C virus (HCV) by MultiCode-RTx real-time PCR targeting the HCV 3' untranslated region.
J Clin Microbiol. 2009 Aug;47(8):2635-8. doi: 10.1128/JCM.02170-08. Epub 2009 Jun 17.
8
Optimization of an unnatural base pair toward natural-like replication.
J Am Chem Soc. 2009 Mar 11;131(9):3246-52. doi: 10.1021/ja807853m.
9
Detection of cytomegalovirus in whole blood using three different real-time PCR chemistries.
J Mol Diagn. 2009 Jan;11(1):54-59. doi: 10.2353/jmoldx.2009.080073. Epub 2008 Dec 12.
本文引用的文献
1
Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency.
J Clin Microbiol. 2006 Jul;44(7):2612-4. doi: 10.1128/JCM.00449-06.
2
Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experience.
J Acquir Immune Defic Syndr. 2006 Apr 1;41(4):439-46. doi: 10.1097/01.qai.0000219290.49152.6a.
3
Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission.
Proc Natl Acad Sci U S A. 2006 May 2;103(18):7094-9. doi: 10.1073/pnas.0602033103. Epub 2006 Apr 25.
4
Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy.
AIDS. 2006 Mar 21;20(5):701-10. doi: 10.1097/01.aids.0000216370.69066.7f.
5
Comparative performance evaluation of the HIV-1 LiPA protease and reverse transcriptase resistance assay on clinical isolates.
J Clin Virol. 2005 Dec;34(4):268-71. doi: 10.1016/j.jcv.2005.01.011.
6
Sensitive phenotypic detection of minor drug-resistant human immunodeficiency virus type 1 reverse transcriptase variants.
J Clin Microbiol. 2005 Nov;43(11):5696-704. doi: 10.1128/JCM.43.11.5696-5704.2005.
7
Detection of minor populations of drug-resistant HIV-1 in acute seroconverters.
AIDS. 2005 Nov 4;19(16):1819-25. doi: 10.1097/01.aids.0000189878.97480.ed.
8
Quantifying mixed populations of drug-resistant human immunodeficiency virus type 1.
Antimicrob Agents Chemother. 2005 Aug;49(8):3334-40. doi: 10.1128/AAC.49.8.3334-3340.2005.
9
Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated.
J Infect Dis. 2005 Jul 1;192(1):16-23. doi: 10.1086/430741. Epub 2005 Jun 1.
10
LigAmp for sensitive detection of single-nucleotide differences.
Nat Methods. 2004 Nov;1(2):141-7. doi: 10.1038/nmeth713. Epub 2004 Oct 21.
Zotero 插件